Replies

Guess that serum isn’t so magical after all.

Wonder when they’re going to try the antiviral drug that’s already in Phase III clinical trials as an anti-flu drug?

This one:

http://www.allfordrugs.com/2014/01/09/favipiravir-phase-3-clinical-trials-for-investigational-flu-treatment-drug-started/

Shown to stop ebola cold, POST infection and symptom development in the lab:

http://www.ncbi.nlm.nih.gov/pubmed/24462697

http://www.ncbi.nlm.nih.gov/pubmed/24583123

Japan has a stockpile of this particular drug already in the event of a ‘weird’ variant of influenza. South Korea has already indicated they will be obtaining this drug in the event Ebola gets a toehold there.

Why do we still hear nothing about this drug in our media?

http://www.japantimes.co.jp/news/2014/08/08/national/science-health/ebola-drug-japan-may-emerge-among-key-candidates/

This article discusses the Tekmira treatment and ALSO discusses the Toyama anti-viral compound, Favipiravir, that has received no mention in our US media.